Journal
BIOLOGICAL PSYCHIATRY
Volume 75, Issue 9, Pages 686-692Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2013.05.022
Keywords
Aging; APOE genotype; cognitive function; neurodegeneration; proton magnetic resonance spectroscopy; structural equation modeling
Categories
Funding
- Litwin-Zucker Research Center of the Feinstein Institute for Medical Research (North Shore-Long Island Jewish Health System)
- National Institutes of Health [RO1 AG038734]
- Baxter
- Eli Lilly
- Forest Research Institute
- Genentech
- Merck
- Applied Neurosolutions
Ask authors/readers for more resources
Background: Proton magnetic resonance spectroscopy (H-1-MRS) studies on healthy aging have reported inconsistent findings and have not systematically taken into account the possible modulatory effect of APOE genotype. We aimed to quantify brain metabolite changes in healthy subjects in relation to age and the presence of the APOE E4 genetic risk factor for Alzheimer's disease. Additionally, we examined these measures in relation to cognition. Methods: We studied a cohort of 112 normal adults between 50 and 86 years old who were genotyped for APOE genetic polymorphism. Measurements of H-1-MRS metabolites were obtained in the posterior cingulate and precuneus region. Measures of general cognitive functioning, memory, executive function, semantic fluency, and speed of processing were also obtained. Results: General linear model analysis demonstrated that older APOE E4 carriers had significantly higher choline/creatine and myoinositol/creatine ratios than APOE E3 homozygotes. Structural equation modeling resulted in a model with an excellent goodness of fit and in which the APOE x age interaction and APOE status each had a significant effect on H-1-MRS metabolites (choline/creatine and myo-inositol/creatine). Furthermore, the APOE x age variable modulation of cognition was mediated by H-1-MRS metabolites. Conclusions: In a healthy aging normal population, choline/creatine and myo-inositol/creatine ratios were significantly increased in APOE E4 carriers, suggesting the presence of neuroinflammatory processes and greater membrane turnover in older carriers. Structural equation modeling analysis confirmed these possible neurodegenerative markers and also indicated the mediator role of these metabolites on cognitive performance among older APOE E4 carriers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available